229 related articles for article (PubMed ID: 3824380)
1. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.
Andersen ME; Clewell HJ; Gargas ML; Smith FA; Reitz RH
Toxicol Appl Pharmacol; 1987 Feb; 87(2):185-205. PubMed ID: 3824380
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models.
Reitz RH; Mendrala AL; Guengerich FP
Toxicol Appl Pharmacol; 1989 Feb; 97(2):230-46. PubMed ID: 2922756
[TBL] [Abstract][Full Text] [Related]
3. DNA-protein cross-links (DPX) and cell proliferation in B6C3F1 mice but not Syrian golden hamsters exposed to dichloromethane: pharmacokinetics and risk assessment with DPX as dosimeter.
Casanova M; Conolly RB; Heck H d'A
Fundam Appl Toxicol; 1996 May; 31(1):103-16. PubMed ID: 8998946
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans.
Andersen ME; Clewell HJ; Gargas ML; MacNaughton MG; Reitz RH; Nolan RJ; McKenna MJ
Toxicol Appl Pharmacol; 1991 Mar; 108(1):14-27. PubMed ID: 1900959
[TBL] [Abstract][Full Text] [Related]
5. Dichloromethane (methylene chloride): metabolism to formaldehyde and formation of DNA-protein cross-links in B6C3F1 mice and Syrian golden hamsters.
Casanova M; Deyo DF; Heck H
Toxicol Appl Pharmacol; 1992 May; 114(1):162-5. PubMed ID: 1585369
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromethane during moderate to heavy exercise.
Jonsson F; Bois F; Johanson G
Toxicol Sci; 2001 Feb; 59(2):209-18. PubMed ID: 11158713
[TBL] [Abstract][Full Text] [Related]
7. Dichloromethane metabolism to formaldehyde and reaction of formaldehyde with nucleic acids in hepatocytes of rodents and humans with and without glutathione S-transferase T1 and M1 genes.
Casanova M; Bell DA; Heck HD
Fundam Appl Toxicol; 1997 Jun; 37(2):168-80. PubMed ID: 9242590
[TBL] [Abstract][Full Text] [Related]
8. Review of investigations of dichloromethane metabolism and subchronic oral toxicity as the basis for the design of chronic oral studies in rats and mice.
Kirschman JC; Brown NM; Coots RH; Morgareidge K
Food Chem Toxicol; 1986 Sep; 24(9):943-9. PubMed ID: 3781441
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling for in vivo inhalation gas uptake data exposure in female B6C3F1 mice.
Evans MV; Caldwell JC
Toxicol Appl Pharmacol; 2010 May; 244(3):280-90. PubMed ID: 20153349
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment.
Reitz RH; Mendrala AL; Park CN; Andersen ME; Guengerich FP
Toxicol Lett; 1988 Oct; 43(1-3):97-116. PubMed ID: 3176073
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of dichloromethane. II. Disposition in Fischer 344 rats following intravenous and oral administration.
Angelo MJ; Pritchard AB; Hawkins DR; Waller AR; Roberts A
Food Chem Toxicol; 1986 Sep; 24(9):975-80. PubMed ID: 3096854
[TBL] [Abstract][Full Text] [Related]
12. Simulations of methylene chloride pharmacokinetics using a physiologically based model.
Angelo MJ; Pritchard AB
Regul Toxicol Pharmacol; 1984 Dec; 4(4):329-39. PubMed ID: 6441198
[TBL] [Abstract][Full Text] [Related]
13. The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model.
Dankovic DA; Bailer AJ
Fundam Appl Toxicol; 1994 Jan; 22(1):20-5. PubMed ID: 8125209
[TBL] [Abstract][Full Text] [Related]
14. Use of the vial equilibration technique for determination of metabolic rate constants for dichloromethane.
Kim C; Manning RO; Brown RP; Bruckner JV
Toxicol Appl Pharmacol; 1996 Aug; 139(2):243-51. PubMed ID: 8806840
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of dichloromethane. I. Disposition in B6C3F1 mice following intravenous and oral administration.
Angelo MJ; Pritchard AB; Hawkins DR; Waller AR; Roberts A
Food Chem Toxicol; 1986 Sep; 24(9):965-74. PubMed ID: 3096853
[TBL] [Abstract][Full Text] [Related]
16. Assessing the relevance of rodent data on chemical interactions for health risk assessment purposes: a case study with dichloromethane-toluene mixture.
Pelekis M; Krishnan K
Regul Toxicol Pharmacol; 1997 Feb; 25(1):79-86. PubMed ID: 9056503
[TBL] [Abstract][Full Text] [Related]
17. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.
Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA
Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684
[TBL] [Abstract][Full Text] [Related]
18. Gas uptake studies of deuterium isotope effects on dichloromethane metabolism in female B6C3F1 mice in vivo.
Andersen ME; Clewell HJ; Mahle DA; Gearhart JM
Toxicol Appl Pharmacol; 1994 Sep; 128(1):158-65. PubMed ID: 8079349
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-mediated dichloromethane toxicity and mutagenicity of bacterial and mammalian dichloromethane-active glutathione S-transferases.
Gisi D; Leisinger T; Vuilleumier S
Arch Toxicol; 1999 Mar; 73(2):71-9. PubMed ID: 10350186
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of the nature of mouse and human GST T1-1 and the implications on dichloromethane carcinogenicity.
Sherratt PJ; Williams S; Foster J; Kernohan N; Green T; Hayes JD
Toxicol Appl Pharmacol; 2002 Mar; 179(2):89-97. PubMed ID: 11884241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
